Cargando…

Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design

Pfs28 is a Plasmodium falciparum malaria transmission-blocking vaccine candidate that is anchored to the parasite surface through a C-terminal glycosylphosphatidylinositol (GPI) moiety, and plays a role in parasite survival in the mosquito midgut. Pfs28 contains epidermal growth factor (EGF)-like do...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Niharika, Tang, Wai Kwan, Tolia, Niraj H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664031/
https://www.ncbi.nlm.nih.gov/pubmed/36379968
http://dx.doi.org/10.1038/s41598-022-24054-3
_version_ 1784831013604556800
author Shukla, Niharika
Tang, Wai Kwan
Tolia, Niraj H.
author_facet Shukla, Niharika
Tang, Wai Kwan
Tolia, Niraj H.
author_sort Shukla, Niharika
collection PubMed
description Pfs28 is a Plasmodium falciparum malaria transmission-blocking vaccine candidate that is anchored to the parasite surface through a C-terminal glycosylphosphatidylinositol (GPI) moiety, and plays a role in parasite survival in the mosquito midgut. Pfs28 contains epidermal growth factor (EGF)-like domains and is part of a family of sexual stage malaria proteins that includes the related vaccine antigen Pfs25. The lack of structural definition of Pfs28 and the immune response to this candidate has limited further malaria vaccine development for this antigen. Here, we present the crystal structure of Pfs28, examine its conservation with P. vivax Pvs28, and evaluate the cross-reactivity of Pfs28 to antibodies that recognize Pfs25. Pfs28 is comprised of four EGF-like domains stabilized by ten disulfide bridges with an overall architecture that highly resembles Pfs25. Despite the high sequence and structural similarity between these antigens, no cross reactivity of Pfs28 to anti-Pfs25 monoclonal antibodies could be demonstrated.
format Online
Article
Text
id pubmed-9664031
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96640312022-11-14 Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design Shukla, Niharika Tang, Wai Kwan Tolia, Niraj H. Sci Rep Article Pfs28 is a Plasmodium falciparum malaria transmission-blocking vaccine candidate that is anchored to the parasite surface through a C-terminal glycosylphosphatidylinositol (GPI) moiety, and plays a role in parasite survival in the mosquito midgut. Pfs28 contains epidermal growth factor (EGF)-like domains and is part of a family of sexual stage malaria proteins that includes the related vaccine antigen Pfs25. The lack of structural definition of Pfs28 and the immune response to this candidate has limited further malaria vaccine development for this antigen. Here, we present the crystal structure of Pfs28, examine its conservation with P. vivax Pvs28, and evaluate the cross-reactivity of Pfs28 to antibodies that recognize Pfs25. Pfs28 is comprised of four EGF-like domains stabilized by ten disulfide bridges with an overall architecture that highly resembles Pfs25. Despite the high sequence and structural similarity between these antigens, no cross reactivity of Pfs28 to anti-Pfs25 monoclonal antibodies could be demonstrated. Nature Publishing Group UK 2022-11-15 /pmc/articles/PMC9664031/ /pubmed/36379968 http://dx.doi.org/10.1038/s41598-022-24054-3 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Shukla, Niharika
Tang, Wai Kwan
Tolia, Niraj H.
Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title_full Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title_fullStr Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title_full_unstemmed Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title_short Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
title_sort structural analysis of plasmodium falciparum ookinete surface antigen pfs28 relevant for malaria vaccine design
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664031/
https://www.ncbi.nlm.nih.gov/pubmed/36379968
http://dx.doi.org/10.1038/s41598-022-24054-3
work_keys_str_mv AT shuklaniharika structuralanalysisofplasmodiumfalciparumookinetesurfaceantigenpfs28relevantformalariavaccinedesign
AT tangwaikwan structuralanalysisofplasmodiumfalciparumookinetesurfaceantigenpfs28relevantformalariavaccinedesign
AT tolianirajh structuralanalysisofplasmodiumfalciparumookinetesurfaceantigenpfs28relevantformalariavaccinedesign